Clinical remission in patients with severe eosinophilic asthma treated with benralizumab who were randomised to reduce their inhaled corticosteroid/formoterol dose: SHAMAL post-hoc analysis

被引：0
|
作者：
Devouassoux, Gilles [1 ,2 ,3 ]
Jackson, David J. [4 ]
Kaessner, Frank F. [5 ]
Caruso, Cristiano [6 ]
Shavit, Anat [7 ]
Olinger, Lynda [8 ,9 ]
Menzies-Gow, Andrew [7 ]
机构：
[1] Hop Croix Rousse, Serv Pneumol, Lyon, France
[2] Univ Claude Bernard Lyon 1, VIRPATH, Villeurbanne, France
[3] CRISALIS, F CRIN INSERM Network, Pavillon Ler, Toulouse, France
[4] Kings Coll London, Guys Hosp, Sch Immunol & Microbial Sci, London, England
[5] MECS GmbH, Ambulantes Zentrum Lungenkrankheiten & Schlafmed, Cottbus, Brandenburg, Germany
[6] Fdn Policlin Univ Agostino Gemelli IRCCS, UOSD DH Internal Med & Digest Dis, Rome, Italy
[7] AstraZeneca, BioPharmaceut Med Resp & Immunol, Cambridge, England
[8] Cytel Inc, Waltham, MA USA
[9] AstraZeneca, BioPharmaceut R&D, Late Stage Dev Resp & Immunol, Cambridge, England
来源：
EUROPEAN RESPIRATORY JOURNAL | 2024年 / 64卷
关键词：
D O I：
10.1183/13993003.congress-2024.PA1194
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 46 条
  • [31] IMPACT OF CLINICAL REMISSION ON PHYSICAL FUNCTION IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH ALX-0061: POST-HOC ANALYSIS OF PHASE I/II DATA
    Van Beneden, K.
    Verschueren, K.
    Willems, W.
    Wouters, H.
    D'Artois, J.
    De Swert, K.
    Arold, G.
    De Bruyn, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 506 - 506
  • [32] Impact of Clinical Remission on Physical Function in Patients with Rheumatoid Arthritis Treated with ALX-0061: Post-Hoc Analysis of Phase I/II Data.
    Van Beneden, Katrien
    Verschueren, Katrien
    Willems, Wouter
    Wouters, Heidi
    D'Artois, Joke
    De Swert, Katelijne
    De Bruyn, Steven
    Arold, Gerhard
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S650 - S650
  • [33] Attainment of remission and low disease activity after treatment with belimumab in patients with systemic lupus erythematosus: a post-hoc analysis of pooled data from five randomised clinical trials
    Parodis, Ioannis
    Lindblom, Julius
    Levy, Roger A.
    Zen, Margherita
    Cetrez, Nursen
    Gomez, Alvaro
    Oon, Shereen
    Henning, Christine
    Khamashta, Munther
    Quasny, Holly A.
    Chauhan, Deven
    Askanase, Anca
    van Vollenhoven, Ronald
    Nikpour, Mandana
    LANCET RHEUMATOLOGY, 2024, 6 (11): : e751 - e761
  • [34] Effect of a single day of increased as-needed budesonide-formoterol use on short-term risk of severe exacerbations in patients with mild asthma: a post-hoc analysis of the SYGMA 1 study
    O'Byrne, Paul M.
    FitzGerald, J. Mark
    Bateman, Eric D.
    Barnes, Peter J.
    Zheng, Jinping
    Gustafson, Per
    Lamarca, Rosa
    Puu, Margareta
    Keen, Christina
    Alagappan, Vijay K. T.
    Reddel, Helen K.
    LANCET RESPIRATORY MEDICINE, 2021, 9 (02): : 149 - 158
  • [35] ACHIEVEMENT OF CLINICAL AND ENDOSCOPIC OUTCOMES BY BASELINE CORTICOSTEROID USE IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO RECEIVED RISANKIZUMAB INDUCTION TREATMENT: A POST-HOC ANALYSIS OF THE INSPIRE STUDY
    Bossuyt, Peter
    Louis, Edouard
    Gecse, Krisztina
    Abreu, Maria T.
    Gionchetti, Paolo
    Rubin, David T.
    Marced, Elena
    Gonzalez, Yuri Sanchez
    Hecht, Patrick
    Kalabic, Jasmina
    Vladea, Ramona C.
    Zhang, Yafei
    Reinisch, Walter
    GASTROENTEROLOGY, 2024, 166 (05) : S806 - S807
  • [36] Increasing the Etanercept Dose in Juvenile Idiopathic Arthritis Patients: Does It Help Reaching the Treatment Target? A Post-hoc Analysis of the Best4Kids Randomised Clinical Trial
    van Dijk, Bastiaan
    Bergstra, Sytske Anne
    van den Berg, Merlijn
    Schonenberg-Meinema, Dieneke
    van Suijlekom-Smit, Lisette
    van Rossum, Marion
    Koopman, Yvonne
    Ten Cate, Rebecca
    Allaart, C. F.
    Brinkman, Danielle
    Muller, Petra Hissink
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 707 - 709
  • [37] Effect of Baseline MTX Dose on Clinical Efficacy and Safety in Rheumatoid Arthritis Patients Treated with Filgotinib: Post-Hoc Analysis from a Phase 2B Study
    Westhovens, Rene
    van der Aa, Annegret
    Jamoul, Corinne
    Tasset, Chantal
    Harrison, Pille
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [38] Characteristics of filgotinib-treated patients with Ulcerative Colitis who achieve sustained corticosteroid-free remission: Post hoc analysis of the phase 2b/3 SELECTION study
    Kobayashi, T.
    Dignass, A.
    Roblin, X.
    Fujitani, Y.
    Oortwijn, A.
    Jamoul, C.
    Hibi, T.
    JOURNAL OF CROHNS & COLITIS, 2023, 17 : 459 - 460
  • [39] Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial
    Puig, Luis
    Costanzo, Antonio
    de Jong, Elke M. G. J.
    Torres, Tiago
    Warren, Richard B.
    Wapenaar, Robert
    Wegner, Sven
    Gorecki, Patricia
    Gramiccia, Talia
    Jazra, Maria
    Buyze, Jozefien
    Conrad, Curdin
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2024, 25 (02) : 315 - 325
  • [40] Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for ≥ 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial
    Luis Puig
    Antonio Costanzo
    Elke M. G. J. de Jong
    Tiago Torres
    Richard B. Warren
    Robert Wapenaar
    Sven Wegner
    Patricia Gorecki
    Talia Gramiccia
    Maria Jazra
    Jozefien Buyze
    Curdin Conrad
    American Journal of Clinical Dermatology, 2024, 25 : 315 - 325
12345